# Javara

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/javara

- Industry: Healthcare
- Headquarters: Winston-Salem, US
- Website: www.javararesearch.com
- Total disclosed funding: $30M
- Latest round: Series B (Apr 1, 2022)
- Investors on record: 1

## About

Based in North Carolina, US, and founded in 2018 by its CEO, Jennifer Byrne, Javara Inc., operates as clinical research as a care option (CRAACO) company that provides healthcare research services. In April 2022, Javara, Inc. raised USD 30 million in series B funding from new investor General Atlantic, with participation from other unspecified investors.

The company offers clinical research solutions that help biopharma, biotech, and CRO (clinical research organization) companies like Priva Medical Group, Tryon Medical Partners, and Wake Forest Baptist Health with their product testing and product approvals.

The company plans to use the April 2022 funding to drive geographic expansion and technological advancements, allowing it to further propel the integration of clinical research into the healthcare ecosystem and provide access to clinical trials to more patients at the point of care through their trusted physician.

## Funding rounds

- Series B, Apr 1, 2022, $30M — General Atlantic

## Investors

- General Atlantic (https://capitalatlas.ai/funds/general-atlantic) — Series B